Bibliography
- Neofytos D , HornD, AnaissieEet al. : Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.Clin. Infect. Dis.48(3) , 265–273 (2009).
- Kontoyiannis DP , MarrKA, ParkBJet al. : Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.Clin. Infect. Dis.50(8) , 1091–1100 (2010).
- Verweij PE , HowardSJ, MelchersWJ, DenningDW: Azole-resistance in Aspergillus: proposed nomenclature and breakpoints.Drug Resist. Updat.12(6) , 141–147 (2009).
- Khoder A , PetrouM, ThomasCet al. : Retrospective study of clinical predictors of positive fungal cultures in recipients of allogeneic and autologous stem cell transplantation.Bone Marrow Transplant.45(Suppl. 2) , S228, poster P772 (2010).
- Sinkó J , CsomorJ, NikolovaRet al. : Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.Transpl. Infect. Dis.10(2) , 106–109 (2008).
- Gil L , MolA, CzyzAet al. : Galactomannan-driven diagnostic strategy of invasive aspergillosis in patients with graft-versus-host disease after allogeneic haematopoietic stem cell transplantation good correlation between serum and bronchoalveolar lavage galactomannan testing.Bone Marrow Transplant.45(Suppl. 2) , S208, poster P720 (2010).
- Maertens J , MaertensV, TheunissenKet al. : Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.Clin. Infect. Dis.49 , 1688–1693 (2009).
- White PL , BretagneS, KlingsporLet al. Aspergillus PCR: one step closer towards standardisation. J. Clin. Microbiol. 48 , 1231–1240 (2010).
- Walsh TJ , AnaissieEJ, DenningDWet al. : Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.Clin. Infect. Dis.46 , 327–360 (2008).
- Slavin MA , OsborneB, AdamsRet al. : Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation a prospective, randomized, double-blind study.J. Infect. Dis.171(6) , 1545–1552 (1995).
- Goodman JL , WinstonDJ, GreenfieldRAet al. : A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.N. Engl. J. Med.326(13) , 845–851 (1992).
- Ullmann AJ , LiptonJH, VesoleDHet al. : Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.N. Engl. J. Med.356 , 335–347 (2007).
- Sinkó J , LengyelL, BartaAet al. : Antifungal prophylaxis with posaconazole in different risk-groups of allograft recipients.Bone Marrow Transplant.45(Suppl. 2) , S234, poster 789 (2010).
- Marks DI , KibblerC, CookGet al. : Voriconazole or itraconazole for antifungal prophylaxis in patients with Grade II to IV acute or extensive chronic graft-versus-host disease.Bone Marrow Transplant.45(Suppl. 2) , S209, poster 723 (2010).
- de la Serna J , JarqueI, LópezJet al. : The effectiveness of liposomal amphotericin in the treatment of invasive fungal infections is not affected by prior azole administration: the Ambi-Prof study.Bone Marrow Transplant.45(Suppl. 2) , S214, poster 735 (2010).
- Dignan FL , EvansSO, EthellMEet al. : An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality.Bone Marrow Transplant.44(1) , 51–56 (2009).
- Martin-Peña A , Aguillar-GuisadoM, EspigadoIet al. : Indication of empirical antifungal therapy in selected patients with persistent febrile neutropenia according to clinical criteria and risk profile.Bone Marrow Transplant.45(Suppl. 2) , S229, poster 775 (2010).
- Cornely O , VehreschildJJ, RüpingMet al. : A phase II dose escalation study of caspofungin for invasive aspergillosis.Bone Marrow Transplant.45(Suppl. 2) , S218, poster 747 (2010).
- Lellek H , DahlkeF, AyukFAet al. : Caspofungin plus posaconazole as salvage therapy fo invasive fungal infections in haematopoietic cell transplantation.Bone Marrow Transplant.45(Suppl. 2) , S233, poster 787 (2010).
- Sirohi B , ChandrasekarP, SeibelNet al. : Efficacy of micafungin in neutropenic patients with invasive candidiasis and candidaemia.Bone Marrow Transplant.45(Suppl. 2) , S220, poster 751 (2010).
- Dony A , GoutagnyMP, BertrandYet al. : Efficacy and safety of caspofungin in paediatric allogeneic haematopoietic stem cell transplantation: a single-centre study.Bone Marrow Transplant.45(Suppl. 2) , S222, poster 755 (2010).
- Döring M , HandgretingerR, MüllerI: Safety and feasibility of posaconazole as oral antifungal prophylaxis in paediatric patients under 12 years of age following allogeneic HSCT.Bone Marrow Transplant.45(Suppl. 2) , S232, poster 785 (2010).
Websites
- 3rd European Conference on Infections in Leukaemia (ECIL). Antifungal prophylaxis in leukaemia patients. Update of the ECIL-1 and -2 guidelines www.ebmt.org/5WorkingParties/IDWP/ECIL3%20%20Antifungal%20prophylaxis%20update%202009.pdf